Agilent Technologies Inc (A) - Total Assets
Based on the latest financial reports, Agilent Technologies Inc (A) holds total assets worth $12.73 Billion USD as of October 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore A debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Agilent Technologies Inc - Total Assets Trend (1998–2025)
This chart illustrates how Agilent Technologies Inc's total assets have evolved over time, based on quarterly financial data. See net assets of Agilent Technologies Inc for net asset value and shareholders' equity analysis.
Agilent Technologies Inc - Asset Composition Analysis
Current Asset Composition (October 2025)
Agilent Technologies Inc's total assets of $12.73 Billion consist of 36.1% current assets and 63.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 14.1% |
| Accounts Receivable | $1.49 Billion | 11.7% |
| Inventory | $1.02 Billion | 8.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $445.00 Million | 3.5% |
| Goodwill | $4.47 Billion | 35.2% |
Asset Composition Trend (1998–2025)
This chart illustrates how Agilent Technologies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see A market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Agilent Technologies Inc's current assets represent 36.1% of total assets in 2025, a decrease from 61.7% in 1998.
- Cash Position: Cash and equivalents constituted 14.1% of total assets in 2025, up from 0.0% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 38.0% of total assets, an increase from 0.0% in 1998.
- Asset Diversification: The largest asset category is goodwill at 35.2% of total assets.
Agilent Technologies Inc Competitors by Total Assets
Key competitors of Agilent Technologies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cowealth Medical China Co.Ltd.
SHG:603122
|
China | CN¥1.41 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Chemclin Diagnostics Co. Ltd. A
SHG:688468
|
China | CN¥1.76 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
|
SCOPE FLUIDICS SA ZY-10
F:S84
|
Germany | €195.94 Million |
|
Avricore Health Inc
V:AVCR
|
Canada | CA$563.12K |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
Agilent Technologies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.96 | 2.09 | 2.06 |
| Quick Ratio | 1.52 | 1.58 | 1.62 |
| Cash Ratio | 0.00 | 0.70 | 0.00 |
| Working Capital | $2.25 Billion | $2.06 Billion | $1.80 Billion |
Agilent Technologies Inc - Advanced Valuation Insights
This section examines the relationship between Agilent Technologies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.60 |
| Latest Market Cap to Assets Ratio | 3.14 |
| Asset Growth Rate (YoY) | 7.4% |
| Total Assets | $12.73 Billion |
| Market Capitalization | $40.01 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Agilent Technologies Inc's assets at a significant premium (3.14x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Agilent Technologies Inc's assets grew by 7.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Agilent Technologies Inc (1998–2025)
The table below shows the annual total assets of Agilent Technologies Inc from 1998 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-10-31 | $12.73 Billion | +7.44% |
| 2024-10-31 | $11.85 Billion | +10.06% |
| 2023-10-31 | $10.76 Billion | +2.19% |
| 2022-10-31 | $10.53 Billion | -1.62% |
| 2021-10-31 | $10.71 Billion | +11.20% |
| 2020-10-31 | $9.63 Billion | +1.85% |
| 2019-10-31 | $9.45 Billion | +10.67% |
| 2018-10-31 | $8.54 Billion | +1.36% |
| 2017-10-31 | $8.43 Billion | +7.79% |
| 2016-10-31 | $7.82 Billion | +4.56% |
| 2015-10-31 | $7.48 Billion | -30.52% |
| 2014-10-31 | $10.76 Billion | +0.69% |
| 2013-10-31 | $10.69 Billion | +1.42% |
| 2012-10-31 | $10.54 Billion | +16.33% |
| 2011-10-31 | $9.06 Billion | -6.59% |
| 2010-10-31 | $9.70 Billion | +27.38% |
| 2009-10-31 | $7.61 Billion | +2.35% |
| 2008-10-31 | $7.44 Billion | -1.55% |
| 2007-10-31 | $7.55 Billion | +2.51% |
| 2006-10-31 | $7.37 Billion | +9.15% |
| 2005-10-31 | $6.75 Billion | -4.32% |
| 2004-10-31 | $7.06 Billion | +12.05% |
| 2003-10-31 | $6.30 Billion | -23.24% |
| 2002-10-31 | $8.20 Billion | +2.72% |
| 2001-10-31 | $7.99 Billion | -4.13% |
| 2000-10-31 | $8.33 Billion | +53.01% |
| 1999-10-31 | $5.44 Billion | +9.16% |
| 1998-10-31 | $4.99 Billion | -- |
About Agilent Technologies Inc
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrome… Read more